Combined action of paclitaxel and cisplatin against wildtype and resistant human ovarian carcinoma cells.
Levasseur, L M
Combined action of paclitaxel and cisplatin against wildtype and resistant human ovarian carcinoma cells. [electronic resource] - Cancer chemotherapy and pharmacology 1997 - 495-505 p. digital
Publication Type: Journal Article; Research Support, U.S. Gov't, P.H.S.
0344-5704
10.1007/s002800050693 doi
Antineoplastic Combined Chemotherapy Protocols--pharmacology
Cell Division--drug effects
Cisplatin--administration & dosage
Colonic Neoplasms--pathology
Drug Resistance, Neoplasm
Female
Head and Neck Neoplasms--pathology
Humans
Ovarian Neoplasms--pathology
Paclitaxel--administration & dosage
Tumor Cells, Cultured
Combined action of paclitaxel and cisplatin against wildtype and resistant human ovarian carcinoma cells. [electronic resource] - Cancer chemotherapy and pharmacology 1997 - 495-505 p. digital
Publication Type: Journal Article; Research Support, U.S. Gov't, P.H.S.
0344-5704
10.1007/s002800050693 doi
Antineoplastic Combined Chemotherapy Protocols--pharmacology
Cell Division--drug effects
Cisplatin--administration & dosage
Colonic Neoplasms--pathology
Drug Resistance, Neoplasm
Female
Head and Neck Neoplasms--pathology
Humans
Ovarian Neoplasms--pathology
Paclitaxel--administration & dosage
Tumor Cells, Cultured